Buy 5-MeO-MiPT (Moxy) Online | Analytical Research Standard

5-MeO-MiPT, also known by its structural name 5-methoxy-N-methyl-N-isopropyltryptamine and its popular nickname Moxy, is an atypical psychedelic tryptamine. As a structural analog of 5-MeO-DiPT (“Foxy”), it is a vital tool for researchers investigating the complex interactions within the serotonergic system.

Our 5-MeO-MiPT is synthesized to a rigorous purity standard of $\geq 98\%$, verified through GC/MS and NMR analysis, and is available in crystalline solid format for high-precision laboratory use.

Technical Chemical Profile

Property	Value/Data
IUPAC Name	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
CAS Number	96096-55-8
Molecular Formula	$C_{15}H_{22}N_{2}O$
Molar Mass	246.35 $g/mol$
Appearance	White crystalline powder or solid

Pharmacological Research & Mechanism

5-MeO-MiPT is primarily characterized as a non-selective serotonin receptor agonist. Its activity is thought to stem from a high affinity for the 5-HT2A and 5-HT1A receptors. Unlike many other tryptamines, it has been identified as a moderately potent serotonin-norepinephrine reuptake inhibitor (SNRI), while remaining inactive as a dopamine reuptake inhibitor. In animal models, 5-MeO-MiPT exhibits dose-dependent inhibition of sensorimotor responses and has been studied for its potential applications in psychiatric therapy research.

Solubility and Storage Information

For effective laboratory preparation, 5-MeO-MiPT demonstrates the following solubility profile:

• DMSO: 30 $mg/ml$

• DMF: 30 $mg/ml$

• Ethanol: 30 $mg/ml$

• Aqueous Buffers (PBS pH 7.2): 0.5 $mg/ml$

Storage: Store at $-20^{\circ}C$ to ensure long-term stability and integrity of the compound.

Safety and Compliance

Hazard Statement: This material is classified as hazardous. It is strictly for forensic and research applications only and is not intended for human or veterinary use. Buyers are responsible for ensuring compliance with all local and international regulations regarding the acquisition of tryptamine derivatives.

5-MeO-MiPT (Moxy): Comprehensive Technical Profile and Research Applications

5-MeO-MiPT, or 5-methoxy-N-methyl-N-isopropyltryptamine, is a potent synthetic tryptamine belonging to the 5-methoxytryptamine family. Recognized in the scientific community by its nickname Moxy, it serves as a structural analog of 5-MeO-DiPT (“Foxy”) and is primarily utilized in neuropharmacological and forensic research. This compound is characterized by its unique pharmacological profile, which combines traditional serotonergic agonism with distinct monoamine reuptake inhibition.

Chemical Identifiers and Physical Data

To maintain the highest standards of analytical precision, researchers rely on the following verified chemical specifications:

Pharmacodynamics and Mechanism of Action

5-MeO-MiPT is classified as an atypical psychedelic due to its complex interaction with various neurotransmitter systems. Unlike many other tryptamines, it demonstrates a pronounced “body” component relative to its visual effects.

Receptor Agonism

The compound functions as a non-selective serotonin receptor agonist, with high affinity for the following sites:

• 5-HT1A: Demonstrates a binding affinity ($K_{i}$) of approximately 0.058 $\mu M$.

• 5-HT2A: Binds with a $K_{i}$ of 0.163 $\mu M$.

• Secondary Targets: Significant affinity is also noted for 5-HT2C, $\alpha 2$-adrenergic, and imidazoline-1 receptors.

Reuptake Inhibition

Unique among tryptamines, 5-MeO-MiPT acts as a moderately potent serotonin-norepinephrine reuptake inhibitor (SNRI). Analytical assays have identified $IC_{50}$ values for reuptake inhibition at:

• Serotonin (5-HT): 6.4 $\mu M$.

• Norepinephrine (NE): 2.6 $\mu M$.

Notably, research indicates that 5-MeO-MiPT does not significantly affect the reuptake of dopamine or the release of monoamines from synaptosomes.

Research Applications and Behavioral Effects

In laboratory settings, 5-MeO-MiPT is used to study the effects of tryptamine derivatives on sensorimotor responses and neuropharmacology.

• Pharmacological Profile: At lower concentrations (e.g., 4–6 mg in oral models), it exhibits stimulatory and entactogenic properties similar to MDMA. At higher concentrations, its effects shift toward classical psychedelic profiles resembling 5-MeO-DMT.

• Forensic and Toxicology Research: It serves as an essential reference material for forensic chemistry and the development of detection methods in behavioral toxicology.

Toxicology and Safety Profiles

Recent in vivo acute toxicity studies in animal models have provided critical data on the safety profile of 5-MeO-MiPT:

• Apoptotic Activity: High-dose exposure (e.g., 2.7 mg/kg) has been shown to induce apoptotic cell death in the liver, kidney, and brain, indicated by significant increases in Caspase-3 positive cells.

• Biodistribution: Following administration, the compound is detectable in the blood, liver, kidneys, and brain tissues.

Storage and Solubility

For long-term preservation of chemical integrity, 5-MeO-MiPT should be stored at $-20^{\circ}C$. The compound exhibits high solubility in organic solvents:

• DMSO / DMF / Ethanol: 30 $mg/ml$.

• Ethanol:PBS (pH 7.2): 0.5 $mg/ml$.

---

Safety Disclaimer: 5-MeO-MiPT is considered a hazardous material. It is strictly intended for forensic and research applications only. It is not for human or veterinary use. Proper protective equipment must be used, and Safety Data Sheets (SDS) should be reviewed prior to handling.